Articles dans des revues avec comité de lecture (23)
  1. 1. Coulonval, K., Vercruysse, V., Paternot, S., Pita, J. M., Corman, R., Raspé, E., & Roger, P. P. (2022). Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27. Cell cycle (Georgetown, Tex.), 21(1), PMC8837260, 12-32. doi:10.1080/15384101.2021.1984663
  2. 2. Ouziel, R., Trepo, E., Cremer, A., Moreno, C., Degré, D., Chaouni, M., Vercruysse, V., Quertinmont, E., Devière, J., Lemmers, A., & Gustot, T. (2013). Correction of all-trans retinoic acid deficiency in alcoholic cirrhosis lessens the excessive inflammatory monocyte response: a translational study. Liver international. doi:10.1111/liv.12249
  3. 3. Lemaire, A., Trepo, E., Ouziel, R., Gustot, T., Moreno, C., Degré, D., Minsart, C., Quertinmont, E., Vercruysse, V., De Wilde, V., Le Moine, O., Devière, J., Abramowicz, M., Le Moine, A., & Lemmers, A. (2013). Microsatellite polymorphism in the heme oxygenase-1 gene promoter is not associated with alcoholic liver disease severity. Hepatology, 59(1), 352-353. doi:10.1002/hep.26534
  4. 4. Trepo, E., Ouziel, R., Pradat, P., Momozawa, Y., Quertinmont, E., Gervy, C., Gustot, T., Degré, D., Vercruysse, V., Deltenre, P., Verset, L., Gulbis, B., Franchimont, D., Devière, J., Lemmers, A., & Moreno, C. (2013). Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. Journal of hepatology, 59(2), 344-350. doi:10.1016/j.jhep.2013.03.024
  5. 5. Degré, D., Lemmers, A., Gustot, T., Ouziel, R., Trepo, E., Demetter, P., Verset, L., Quertinmont, E., Vercruysse, V., Le Moine, O., Devière, J., & Moreno, C. (2012). Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates. Clinical and experimental immunology, 169(3), 302-310. doi:10.1111/j.1365-2249.2012.04609.x
  6. 6. Ouziel, R., Gustot, T., Moreno, C., Arvanitakis, M., Degré, D., Trepo, E., Quertinmont, E., Vercruysse, V., Demetter, P., Le Moine, O., McKenzie, A., Delhaye, M., Devière, J., & Lemmers, A. (2012). The ST2 Pathway Is Involved in Acute Pancreatitis: A Translational Study in Humans and Mice. The American journal of pathology, 180(6), 2330-2339. doi:10.1016/j.ajpath.2012.03.009
  7. 7. Trepo, E., Gustot, T., Degré, D., Lemmers, A., Verset, L., Demetter, P., Ouziel, R., Quertinmont, E., Vercruysse, V., Amininejad, L., Deltenre, P., Le Moine, O., Devière, J., Franchimont, D., & Moreno, C. (2011). Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. Journal of hepatology, 55(4), 906-912. doi:10.1016/j.jhep.2011.01.028
  8. 8. Lemmers, A., Gustot, T., Durnez, A., Evrard, S., Moreno, C., Quertinmont, E., Vercruysse, V., Demetter, P., Franchimont, D., Le Moine, O., Geerts, A., & Devière, J. (2009). An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease. Clinical and experimental immunology, 156(3), 518-527. doi:10.1111/j.1365-2249.2009.03916.x
  9. 9. Lemmers, A., Moreno, C., Gustot, T., Marechal, R., Degré, D., Demetter, P., De Nadai, P., Geerts, A., Quertinmont, E., Vercruysse, V., Le Moine, O., & Devière, J. (2009). The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology, 49(2), 646-657. doi:10.1002/hep.22680
  10. 10. Lobo, S. M., Soriano, F. G., Barbeiro, D. F., De Backer, D., Sun, Q., Tu, Z., Dimopoulos, G., Preiser, J.-C., Vray, B., Vercruysse, V., & Vincent, J. L. (2009). Effects of dobutamine on gut mucosal nitric oxide production during endotoxic shock in rabbits. Medical Science Monitor, 15(2), BR37-BR42.
  11. 11. Trepo, E., Pradat, P., Young, B., Lagier, R., Moreno, C., Sninsky, J., Lemmers, A., Gustot, T., Degré, D., Vercruysse, V., Quertinmont, E., Trepo, C., & Adler, M. (2009). Role of the cirrhosis risk score (CRS) for the prediction of fibrosis progression in hepatitis C patients with minimal liver disease. Journal of hepatology, 50, 160.
  12. 12. Bruhn, A., Verdant, C., Vercruysse, V., Su, F., Vray, B., & Vincent, J. L. (2006). Effects of dexamethasone on macrophage migration inhibitory factor production in sepsis. Shock, 26(2), 169-173. doi:10.1097/01.shk.0000225416.27742.cb
    13. << Précédent 1 2 3 4 5 Suivant >>